Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base

Author(s):  Friciu Mihaela, Benzina Ouafa, Hunt Kathryn, Cull Erica, LeClair Grégoire

Issue:  Mar/Apr 2026 - Volume 30, Number 2
View All Articles in Issue

Abstract:  Compounded Benzocaine (20%), Lidocaine (6%), and Tetracaine (4%) in VersaPro™ Cream Base was studied to evaluate the chemical, physical, and microbial stability over a 180-day period. Preparations were stored in ambient conditions in tightly closed, light-resistant, metered-dose plastic containers. An HPLC assay was developed and validated to assess chemical stability, while physical stability was assessed by observing organoleptic characteristics and measuring pH levels. Antimicrobial effectiveness testing was conducted according to USP <51> at the final stability time point. The results indicate that combined Benzocaine (20%), Lidocaine (6%), and Tetracaine (4%) compounded in VersaPro™ Cream Base was stable for the duration of the study and may be assigned an extended beyond-use-date of 180 days under the examined conditions.

Related Keywords: Benzocaine, Lidocaine, Tetracaine, BLT, Analgesic, Dermatology, Topical, Cream, VersaPro

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=5535

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products